Cargando…

The Prognostic Value of Pre-Treatment Leukocytosis in Patients with Previously Treated, Stage IIIB/IV Non-Small Cell Lung Cancer Treated with the IGF-1R Pathway Modulator AXL1717 or Docetaxel; a Retrospective Analysis of a Phase II Trial

BACKGROUND: The aim of the present study was to investigate any prognostic value of pre-treatment anemia, leukocytosis and thrombocytosis in patients with advanced pretreated NSCLC. METHODS: A randomized, multicenter phase II study comparing the IGF-1R modulator AXL with standard docetaxel in the tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holgersson, Georg, Bergqvist, Michael, Nilsson, Jonas, Thureson, Marcus, Harmenberg, Johan, Bergstrom, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373797/ https://www.ncbi.nlm.nih.gov/pubmed/28669167 http://dx.doi.org/10.22034/APJCP.2017.18.6.1555

Ejemplares similares

Phase I clinical trial of AXL1717 for treatment of relapsed malignant astrocytomas: analysis of dose and response
por: Aiken, Robert, et al.
Publicado: (2017)

The role of income in brain tumor patients: a descriptive register-based study: No correlation between patients’ income and development of brain cancer
por: Nilsson, Jonas, et al.
Publicado: (2018)

Incidence Rates in Low-Grade Primary Brain Tumors: Are There Differences Between Men and Women? A Systematic Review
por: Nilsson, Jonas, et al.
Publicado: (2016)

Socioeconomy as a prognostic factor for location of death in Swedish palliative cancer patients
por: Nilsson, Jonas, et al.
Publicado: (2021)

Impact of EMT in stage IIIB/IV NSCLC treated with erlotinib and bevacizumab when compared with cisplatin, gemcitabine and bevacizumab
por: Villalobos, Matthias, et al.
Publicado: (2019)

The viceregency of Antonio María Bucareli in New Spain, 1717-1779 /
por: Bobb, Bernard E.
Publicado: (1970)

Targeting AXL overcomes resistance to docetaxel therapy in advanced prostate cancer
por: Lin, Jian-Zhong, et al.
Publicado: (2017)

A randomised phase II trial of docetaxel vs docetaxel and irinotecan in patients with stage IIIb–IV non-small-cell lung cancer who failed first-line treatment
por: Wachters, F M, et al.
Publicado: (2005)

Leukocytosis in Pneumonia
Publicado: (1903)

World Trade in Medicinal Plants from Spanish America, 1717–1815
por: Gänger, Stefanie
Publicado: (2015)

Erlotinib plus tivantinib versus erlotinib alone in patients with previously treated stage IIIb/IV non–small-cell lung cancer: A meta-analysis based on randomized controlled trials
por: Deng, Huan, et al.
Publicado: (2020)

Leukocytosis and neutrophilia predict outcome in locally advanced esophageal cancer treated with definitive chemoradiation
por: Schernberg, Antoine, et al.
Publicado: (2017)

Use of CAM among cancer patients: Results of a regional survey in Sweden
por: Källman, Mikael, et al.
Publicado: (2023)

Cardioprotective mIGF-1/SIRT1 signaling induces hypertension, leukocytosis and fear response in mice
por: Bolasco, Giulia, et al.
Publicado: (2012)

1717. Cryptococcal Meningitis: A Comparison of Clinical Features and Outcomes by HIV Status
por: Pate, Amy, et al.
Publicado: (2019)

Leukocytosis and Spurious Hypoxemia
por: Gupta, Sachin, et al.
Publicado: (2021)

Leukocytosis in Surgical Infections
por: Boswell, Charles O.
Publicado: (1907)

Etiologies of Extreme Leukocytosis
por: Viner, Esther, et al.
Publicado: (2023)

Comparative Effectiveness of Atezolizumab, Nivolumab, and Docetaxel in Patients With Previously Treated Non–Small Cell Lung Cancer
por: Ramagopalan, Sreeram, et al.
Publicado: (2021)

Phase I study of high-dose epirubicin and vinorelbine in previously untreated non-small-cell lung cancer stage IIIB-IV.
por: Bakker, M., et al.
Publicado: (1995)

Leukocytosis and alteration of hemoglobin level in patients with severe COVID‐19: Association of leukocytosis with mortality
por: Sayad, Babak, et al.
Publicado: (2020)

Leukocytosis and alteration of hemoglobin level in patients with severe COVID‐19: Association of leukocytosis with mortality
Publicado: (2020)

A phase II study of the combination of docetaxel and bevacizumab for previously treated non-small cell lung cancer
por: Shimizu, Tetsuo, et al.
Publicado: (2019)

An observational, multicentre study of cabazitaxel in patients with metastatic castration‐resistant prostate cancer previously treated with docetaxel (CAPRISTANA)
por: Carles, Joan, et al.
Publicado: (2018)

Cost-Effectiveness of Tislelizumab Versus Docetaxel for Previously Treated Advanced Non-Small-Cell Lung Cancer in China
por: Gong, Jinhong, et al.
Publicado: (2022)

Undifferentiated prostate cancer treated with docetaxel
por: Kobayashi, Masaki, et al.
Publicado: (2020)

PB1717: CD19-NEGATIVE B- ACUTE LYMPHOBLASTIC LEUKEMIA: WHAT CHALLENGES?
por: Siala, Nour, et al.
Publicado: (2023)

Valproate-related neutropenia and lithium-related leukocytosis in patients treated with clozapine: a retrospective cohort study
por: Yang, Chia-Chun, et al.
Publicado: (2023)

Long-term survival rates of patients with stage IIIB and IV non-small cell lung cancer treated with cisplatin plus vinorelbine or gemcitabine
por: OZKAYA, SEVKET, et al.
Publicado: (2012)

Changes in platelet parameters in leukocytosis
por: Ozturk, Nurinnisa, et al.
Publicado: (2016)

Bupropion-Induced Severe Leukocytosis
por: Jolly, Taranjeet S, et al.
Publicado: (2020)

Safety of enzalutamide in patients with metastatic castration‐resistant prostate cancer previously treated with docetaxel: Expanded access in North America
por: Joshua, Anthony M., et al.
Publicado: (2015)

A Case Series of Survival Outcomes in Patients with Advanced-stage IIIb/IV Non-small-cell Lung Cancer Treated with HangAm-Plus
por: Bang, Sun-Hwi, et al.
Publicado: (2012)

STUDIES ON THE LEUKOCYTOSIS AND LYMPHOCYTOSIS INDUCED BY BORDETELLA PERTUSSIS : III. THE DISTRIBUTION OF TRANSFUSED LYMPHOCYTES IN PERTUSSIS-TREATED AND NORMAL MICE
por: Morse, Stephen I., et al.
Publicado: (1970)

A Prospective Phase I/II Study: Combination Chemotherapy with Docetaxel and Pemetrexed as Second-Line Treatment in Patients with Stage IIIB/IV Non-Small Cell Lung Cancer
por: Kroeber, Vinzenz, et al.
Publicado: (2014)

Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy
por: Taieb, Julien, et al.
Publicado: (2023)

Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma
por: Koukourakis, M I, et al.
Publicado: (1999)

Randomised phase II trial of docetaxel and sunitinib in patients with metastatic gastric cancer who were previously treated with fluoropyrimidine and platinum
por: Yi, J H, et al.
Publicado: (2012)

Phase II Study of Gemcitabine and Docetaxel Combination in Patients with Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Kafri, Zyad, et al.
Publicado: (2012)

Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy: Treatment Patterns From the PROXIMA Prospective Registry
por: Akaza, Hideyuki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b0h9d6iure3bh3hhh176kfsvko